Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cadrenal Therapeutics, Inc.

16.45
-0.0500-0.30%
Post-market: 16.450.00000.00%19:29 EDT
Volume:27.88K
Turnover:464.96K
Market Cap:30.92M
PE:-1.88
High:17.00
Open:16.80
Low:16.29
Close:16.50
Loading ...
Aug 18, 2023

Major Issues Report

Form 8-K - Current report
Aug 16, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 26, 2023

Correspondence

Form CORRESP - Correspondence
Jul 24, 2023

Major Issues Report

Form 8-K - Current report
Jul 24, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jul 14, 2023

Major Issues Report

Form 8-K - Current report
May 26, 2023

Major Issues Report

Form 8-K - Current report
May 10, 2023

Major Issues Report

Form 8-K - Current report
May 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 30, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 27, 2023

Major Issues Report

Form 8-K - Current report
Jan 25, 2023

Major Issues Report

Form 8-K - Current report
Jan 24, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 17, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 17, 2023

Correspondence

Form CORRESP - Correspondence
Jan 17, 2023

Correspondence

Form CORRESP - Correspondence
Dec 28, 2022

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]